Share on PinterestA study on COVID-19 vaccines that was previously blocked by the CDC’s acting director was published in a medical journal. luis velasco/Stocksy A COVID-19 vaccine efficacy study that had previously been blocked by the CDC was published in a scientific journal. Acting CDC Director Jay Bhattacharya blocked the study from appearing in the […]
Read MoreMonth: June 2026
Can GLP-1 Drugs Enhance Athletic Performance?
Share on PinterestGLP-1 drugs can provide benefits that may boost an athlete’s performance, but do these medications give them the competitive edge? Getty Images/The Good Brigade Debates are emerging over whether GLP-1 drugs boost athletic performance. However, experts say the loss of lean mass associated with using these drugs may cancel out any competitive advantages. […]
Read MoreSpecial Edition: Medications in the Pipeline for Cardiometabolic Disease
In this special edition of DOC Updates, Neil Skolnik speaks with Dr. Juan Frias, who catalogues the latest cardiometabolic medications, emphasizing the distinguishing characteristics of each. This special episode is sponsored with support from Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, […]
Read MoreGLP-1 Drugs May Affect Your Sense of Smell, Taste
Share on PinterestSome GLP-1 users report changes in their taste and smell, according to a new study. Tatsiana Volkava/Getty Images Researchers report that GLP-1 drugs used to treat type 2 diabetes may impair a person’s sense of taste and smell. Experts say taste and smell dysfunction doesn’t appear to be a common side effect of […]
Read MoreWhich Is Best for Weight Loss?
Share on PinterestResearchers compared intermittent fasting with calorie counting and found that people following fasting protocols thought about food less often. Anchiy/Getty Images A recent study found that people who bounce from one diet to another — or “yo-yo dieters” — may have better results following an intermittent fasting diet plan. The study compared intermittent […]
Read More$50 GLP-1 Drugs Are Coming for Medicare Recipients
Share on PinterestAn estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials announced the launch of a Medicare GLP-1 Bridge pilot program that reduces the cost of certain GLP-1 medications prescribed for weight loss. Under the program, Wegovy, Foundayo, and Zepbound KwikPens […]
Read MoreSex-Dependent Diabetes Impact of Acute Grp78 Deletion in β-Cells of Adult Mice
GRP78/BiP/HSPA5 is a widely expressed endoplasmic reticulum (ER) chaperone that also performs the critical role of regulating the unfolded protein response, an adaptive mechanism that maintains ER homeostasis. As the exclusive source of circulating insulin, pancreatic β-cells are prone to ER stress due to proinsulin synthesis workload. GRP78 is important for the ER stress response, […]
Read MoreActivating Transcription Factor 6α Governs Stress-Adaptive Pancreatic β-Cell Mass Expansion by Coordinating Proliferation and Survival
Progressive loss of pancreatic β-cell mass (BCM) is a hallmark of type 2 diabetes, yet strategies to preserve or restore BCM remain elusive due to incomplete understanding of the molecular mechanisms governing β-cell proliferation in adults. The unfolded protein response (UPR) maintains endoplasmic reticulum (ER) proteostasis, but the in vivo role of activating transcription factor 6α […]
Read MoreCo-occurrence of Loss-of-Function GCK and ABCC8 Variants in a Pedigree With a Spectrum of Dysglycemia
Glucokinase and ATP-sensitive potassium (KATP) channels in pancreatic β-cells control insulin secretion in response to glucose stimulation to maintain glucose homeostasis. It is well established that loss-of-function (LOF) variants in GCK, which encodes glucokinase, are diabetogenic, whereas LOF variants in KATP channel genes lead to congenital hyperinsulinism (HI) and hypoglycemia. However, how the co-occurrence of […]
Read MoreWhey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes
This study characterized the dose effect of whey protein isolate (WPI) ingestion on glucagon secretion, glycemia, and the underlying mechanisms in adults with type 1 diabetes. Twelve insulin pump–treated adults with type 1 diabetes (mean ± SD age 47.3 ± 16.4 years; BMI 26.1 ± 3.8 kg/m2) and six adults without diabetes (age 36.2 ± […]
Read More